Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Final Results of the Expedited First Sunset Review of the Countervailing Duty Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Department of Commerce (Commerce) finds that revocation of the countervailing duty (CVD) order on sodium gluconate, gluconic acid, and derivative products (sodium gluconate) from the People's Republic of China (China) would be likely to lead to continuation or recurrence of countervailable subsidies at the levels indicated in the "Final Results of Sunset Review" section of this notice.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 23 (Friday, February 2, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 23 (Friday, February 2, 2024)]
[Notices]
[Pages 7375-7376]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02116]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[C-570-072]
Sodium Gluconate, Gluconic Acid, and Derivative Products From the
People's Republic of China: Final Results of the Expedited First Sunset
Review of the Countervailing Duty Order
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) finds that
revocation of the countervailing duty (CVD) order on sodium gluconate,
gluconic acid, and derivative products (sodium gluconate) from the
People's Republic of China (China) would be likely to lead to
continuation or recurrence of countervailable subsidies at the levels
indicated in the ``Final Results of Sunset Review'' section of this
notice.
DATES: Applicable February 2, 2024.
FOR FURTHER INFORMATION CONTACT: Stephanie Trejo, AD/CVD Operations,
Office IV, Enforcement and Compliance, International Trade
Administration, U.S. Department of Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone: (202) 482-4390.
SUPPLEMENTARY INFORMATION:
Background
On November 13, 2018, Commerce published the CVD order on sodium
gluconate from China.\1\ On October 2, 2023, Commerce published the
notice of initiation of the first sunset review of the Order, pursuant
to section 751(c) of the Tariff Act of 1930, as amended (the Act).\2\
On October 12, 2023, Commerce received a timely notice of intent to
participate from PMP Fermentation Products Inc. (the domestic
interested party) within the 15-day deadline specified in 19 CFR
351.218(d)(1)(i).\3\ The domestic interested party claimed interested
party status under section 771(9)(C) of the Act and 19 CFR
351.102(b)(29)(v) as producers of the domestic like product.
---------------------------------------------------------------------------
\1\ See Sodium Gluconate, Gluconic Acid and Derivative Products
from the People's Republic of China: Antidumping and Countervailing
Duty Orders, 83 FR 56299 (November 13, 2018) (Order).
\2\ See Initiation of Five-Year (Sunset) Reviews, 88 FR 67729
(October 2, 2023).
\3\ See Domestic Interested Parties' Letter, ``Sodium Gluconate,
Gluconic Acid, and Derivative Products from the People's Republic of
China--Domestic Interested Parties' Notice of Intent to
Participate,'' dated October 12, 2023.
---------------------------------------------------------------------------
On November 1, 2023, Commerce received an adequate substantive
response to the Initiation Notice from the domestic interested party
within the 30-day deadline specified in 19 CFR 351.218(d)(3)(i).\4\ We
received no substantive responses from any other interested parties,
and no interested party requested a hearing. On November 17, 2023,
Commerce notified the U.S. International Trade Commission that it did
not receive an adequate substantive response from respondent interested
parties, and that Commerce would conduct an expedited (120-day) sunset
review of the Order,\5\ pursuant to section 751(c)(3)(B) of the Act and
19 CFR 351.218(e)(1)(ii)(B)-(C).
---------------------------------------------------------------------------
\4\ See Domestic Interested Parties' Letter, ``Sodium Gluconate,
Gluconic Acid, and Derivative Products from the People's Republic of
China--Domestic Interested Parties' Substantive Response,'' dated
November 1, 2023.
\5\ See Commerce's Letter, ``Sunset Reviews Initiated on October
2, 2023,'' dated November 17, 2023.
---------------------------------------------------------------------------
Scope of the Order
The product covered by the Order is sodium gluconate from China.
For a complete description of the scope of the Order, see the Issues
and Decision Memorandum.\6\
---------------------------------------------------------------------------
\6\ See Memorandum, ``Decision Memorandum for the Final Results
of the First Expedited Sunset Review of the Antidumping Duty Orders
on Sodium Gluconate, Gluconic Acid and Derivative Products from the
People's Republic of China,'' dated concurrently with, and hereby
adopted by, this notice (Issues and Decision Memorandum).
---------------------------------------------------------------------------
Analysis of Comments Received
A complete discussion of all issues raised in this sunset review,
including the likelihood of the continuation or recurrence of
subsidization in the event of revocation of the Order and the
countervailable subsidy rates likely to prevail if the Order were to be
revoked, is provided in the accompanying Issues and Decision
Memorandum. A list of the topics discussed in the Issues and Decision
Memorandum is attached as an appendix to this notice. The Issues and
Decision Memorandum is a public document and is on file electronically
via Enforcement and Compliance's Antidumping and Countervailing Duty
Centralized Electronic Service System (ACCESS), which is available to
registered users at <a href="https://access.trade.gov">https://access.trade.gov</a>. In addition, a complete
version of the Issues and Decision Memorandum can be accessed directly
at <a href="https://access.trade.gov/public/FRNotices/ListLayout.aspx">https://access.trade.gov/public/FRNotices/ListLayout.aspx</a>.
Final Results of Sunset Review
Pursuant to sections 751(c)(1) and 752(b) of the Act, we determine
that revocation of the Order would be likely to lead to continuation or
recurrence of countervailable subsidies at the
[[Page 7376]]
following net countervailable subsidy rates:
------------------------------------------------------------------------
Subsidy rate
Company (percent ad
valorem)
------------------------------------------------------------------------
Qingdao Dongxiao Enterprise Co., Ltd.................... 194.67
Shandong Fuyang Biotechnology Co........................ 194.67
Shandong Kaison Biochemical Co Ltd...................... 194.67
Tongxiang Hongyu Chemical Co., Ltd...................... 194.67
All Others.............................................. 194.67
------------------------------------------------------------------------
Administrative Protective Order
This notice serves as the only reminder to parties subject to an
administrative protective order (APO) of their responsibility
concerning the disposition of proprietary information disclosed under
APO in accordance with 19 CFR 351.305(a), which continues to govern
business proprietary information in this segment of the proceeding.
Timely written notification of the destruction of APO materials or
conversion to judicial protective order is hereby requested. Failure to
comply with the regulations and terms of an APO is a violation which is
subject to sanction.
Notification to Interested Parties
Commerce is issuing and publishing these final results and this
notice in accordance with sections 751(c), 752(b), and 777(i)(1) of the
Act and 19 CFR 351.218.
Dated: January 29, 2024.
Abdelali Elouaradia,
Deputy Assistant Secretary for Enforcement and Compliance.
Appendix
List of Topics Discussed in the Issues and Decision Memorandum
I. Summary
II. Background
III. Scope of the Order
IV. History of the Order
V. Legal Framework
VI. Discussion of the Issues
1. Likelihood of Continuation or Recurrence of a Countervailable
Subsidy
2. Net Countervailable Subsidy Rates Likely To Prevail
3. Nature of the Subsidies
VII. Final Results of Sunset Review
VIII. Recommendation
[FR Doc. 2024-02116 Filed 2-1-24; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.